scispace - formally typeset
K

Katharine J Looker

Researcher at University of Bristol

Publications -  48
Citations -  36036

Katharine J Looker is an academic researcher from University of Bristol. The author has contributed to research in topics: Population & Years of potential life lost. The author has an hindex of 25, co-authored 44 publications receiving 25090 citations. Previous affiliations of Katharine J Looker include Imperial College London & Public Health England.

Papers
More filters
Journal ArticleDOI

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013 : quantifying the epidemiological transition

Christopher J L Murray, +611 more
- 28 Nov 2015 - 
TL;DR: Patterns of the epidemiological transition with a composite indicator of sociodemographic status, which was constructed from income per person, average years of schooling after age 15 years, and the total fertility rate and mean age of the population, were quantified.
Journal ArticleDOI

Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015 : a systematic analysis for the Global Burden of Disease Study 2015

Nicholas J Kassebaum, +682 more
- 08 Oct 2016 - 
TL;DR: In this paper, the authors used the Global Burden of Diseases, Injuries, and Risk Factors Study 2015 (GBD 2015) for all-cause mortality, cause-specific mortality, and non-fatal disease burden to derive HALE and DALYs by sex for 195 countries and territories from 1990 to 2015.
Journal ArticleDOI

Global and Regional Estimates of Prevalent and Incident Herpes Simplex Virus Type 1 Infections in 2012

TL;DR: Genital HSV-1 burden can be substantial but varies widely by region, and future control efforts, including development of HSV vaccines, should consider the epidemiology of HSv-1 in addition toHSV-2, and especially the relative contribution of HS V-1 to genital infection.
Journal ArticleDOI

An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection

TL;DR: The prevalence of HSV-2 is relatively easy to measure since infection is lifelong and has a specific serological test, and the burden of disease is less easy to quantify.
Journal ArticleDOI

Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012.

TL;DR: The global burden of HSV-2 infection is large, leaving over 400 million people at increased risk of genital ulcer disease, HIV acquisition, and transmission of HSv-2 to partners or neonates, highlighting the critical need for development of vaccines, microbicides, and other new HSV prevention strategies.